ABSTRACT
LGR5 marks resident adult epithelial stem cells at the gland base in the mouse pyloric stomach1, but the identity of the equivalent human stem cell population remains unknown owing to a lack of surface markers that facilitate its prospective isolation and validation. In mouse models of intestinal cancer, LGR5+ intestinal stem cells are major sources of cancer following hyperactivation of the WNT pathway2. However, the contribution of pyloric LGR5+ stem cells to gastric cancer following dysregulation of the WNT pathway-a frequent event in gastric cancer in humans3-is unknown. Here we use comparative profiling of LGR5+ stem cell populations along the mouse gastrointestinal tract to identify, and then functionally validate, the membrane protein AQP5 as a marker that enriches for mouse and human adult pyloric stem cells. We show that stem cells within the AQP5+ compartment are a source of WNT-driven, invasive gastric cancer in vivo, using newly generated Aqp5-creERT2 mouse models. Additionally, tumour-resident AQP5+ cells can selectively initiate organoid growth in vitro, which indicates that this population contains potential cancer stem cells. In humans, AQP5 is frequently expressed in primary intestinal and diffuse subtypes of gastric cancer (and in metastases of these subtypes), and often displays altered cellular localization compared with healthy tissue. These newly identified markers and mouse models will be an invaluable resource for deciphering the early formation of gastric cancer, and for isolating and characterizing human-stomach stem cells as a prerequisite for harnessing the regenerative-medicine potential of these cells in the clinic.
Subject(s)
Aquaporin 5/metabolism , Carcinogenesis/pathology , Neoplastic Stem Cells/pathology , Stomach Neoplasms/pathology , Stomach/pathology , Animals , Biomarkers/metabolism , Humans , Mice , Neoplastic Stem Cells/metabolism , Pylorus/pathology , Receptors, G-Protein-Coupled/metabolism , Wnt Signaling PathwayABSTRACT
Filaggrin (FLG) loss-of-function (LOF) variants are a major risk factor for the common inflammatory skin disease, atopic dermatitis (AD) and are often population-specific. African-American (AA) children are disproportionately affected with AD, often later developing asthma and/or allergic rhinitis and comprise an atopy health disparity group for which the role of FLG LOF is not well known. Discovery of FLG LOF using exome sequencing is challenging given the known difficulties for accurate short-read alignment to FLG's high homology repeat variation. Here, we employed an array-based sequencing approach to tile across each FLG repeat and discover FLG LOF in a well-characterized cohort of AA children with moderate-to-severe AD. Five FLG LOF were identified in 23% of our cohort. Two novel FLG LOF singletons, c.488delG and p.S3101*, were discovered as well as p.R501*, p.R826* and p.S3316* previously reported for AD. p.S3316* (rs149484917) is likely an African ancestral FLG LOF, reported in African individuals in ExAC (Exome Aggregation Consortium), Exome Variant Server (ESP), and 4 African 1000G population databases (ESN, MSL, ASW, and ACB). The proportion of FLG LOF (11.5%) among the total FLG alleles in our cohort was significantly higher in comparisons with FLG LOF reported for African individuals in ExAC (2.5%; P = 4.3 × 10-4 ) and ESP (1.7%; P = 3.5 × 10-5 ) suggesting a disease-enrichment effect for FLG LOF. Our results demonstrate the utility of array-based sequencing in discovering FLG LOF, including novel and population-specific, which are of higher prevalence in our AA severe AD group than previously reported.
Subject(s)
Black or African American/genetics , Dermatitis, Atopic/genetics , Intermediate Filament Proteins/genetics , Loss of Function Mutation , Sequence Analysis, DNA/methods , Adolescent , Alleles , Child , Child, Preschool , Exome , Filaggrin Proteins , Humans , Infant , Oligonucleotide Array Sequence Analysis , Severity of Illness IndexSubject(s)
Alleles , Dermatitis, Atopic , Gene Frequency , Ichthyosis , Intermediate Filament Proteins/genetics , Mutation , DNA Mutational Analysis , Dermatitis, Atopic/diagnosis , Dermatitis, Atopic/genetics , Female , Filaggrin Proteins , Humans , Ichthyosis/diagnosis , Ichthyosis/genetics , MaleSubject(s)
Carcinoma, Basal Cell/genetics , Carcinoma, Basal Cell/metabolism , DNA Methylation , Skin Neoplasms/genetics , Skin Neoplasms/metabolism , Transcriptome , Aged , Biopsy , Carcinoma, Basal Cell/diagnostic imaging , Female , Gene Expression Regulation, Neoplastic , Head and Neck Neoplasms/diagnostic imaging , Head and Neck Neoplasms/genetics , Head and Neck Neoplasms/metabolism , Humans , Image Processing, Computer-Assisted , Imaging, Three-Dimensional , Mutation , Neoplasm Invasiveness , Skin Neoplasms/diagnostic imaging , Tomography, X-Ray ComputedABSTRACT
Heterozygous de novo mutations in GATA6 are the most frequent cause of pancreatic agenesis in humans. In mice, however, a similar phenotype requires the biallelic loss of Gata6 and its paralog Gata4. To elaborate the human-specific requirements for GATA6, we chose to model GATA6 loss in vitro by combining both gene-edited and patient-derived pluripotent stem cells (hPSCs) and directed differentiation toward ß-like cells. We find that GATA6 heterozygous hPSCs show a modest reduction in definitive endoderm (DE) formation, while GATA6-null hPSCs fail to enter the DE lineage. Consistent with these results, genome-wide studies show that GATA6 binds and cooperates with EOMES/SMAD2/3 to regulate the expression of cardinal endoderm genes. The early deficit in DE is accompanied by a significant reduction in PDX1+ pancreatic progenitors and C-PEPTIDE+ ß-like cells. Taken together, our data position GATA6 as a gatekeeper to early human, but not murine, pancreatic ontogeny.
Subject(s)
Cell Differentiation , Endoderm/metabolism , GATA6 Transcription Factor/genetics , Gene Regulatory Networks , Insulin-Secreting Cells/metabolism , Pancreas/abnormalities , Pancreatic Diseases/congenital , Pluripotent Stem Cells/metabolism , Cell Lineage , Cells, Cultured , Endoderm/cytology , GATA6 Transcription Factor/metabolism , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Humans , Insulin-Secreting Cells/cytology , Pancreas/metabolism , Pancreatic Diseases/genetics , Pancreatic Diseases/metabolism , Pluripotent Stem Cells/cytology , Protein Binding , Smad2 Protein/genetics , Smad2 Protein/metabolism , Smad3 Protein/genetics , Smad3 Protein/metabolism , T-Box Domain Proteins/genetics , T-Box Domain Proteins/metabolism , Trans-Activators/genetics , Trans-Activators/metabolismABSTRACT
Recessive dystrophic epidermolysis bullosa (RDEB) patients suffer from chronic and repeatedly infected wounds predisposing them to the development of aggressive and life-threatening skin cancer in these areas. Vitamin D3 is an often neglected but critical factor for wound healing. Intact skin possesses the entire enzymatic machinery required to produce active 1-alpha,25-dihydroxyvitamin D3 (calcitriol), underscoring its significance to proper skin function. Injury enhances calcitriol production, inducing the expression of calcitriol target genes including the antimicrobial peptide cathelicidin (hCAP18), an essential component of the innate immune system and an important wound healing factor. We found significantly reduced hCAP18 expression in a subset of RDEB keratinocytes which could be restored by calcipotriol treatment. Reduced scratch closure in RDEB cell monolayers was enhanced up to 2-fold by calcipotriol treatment, and the secretome of calcipotriol-treated cells additionally showed increased antimicrobial activity. Calcipotriol exhibited anti-neoplastic effects, suppressing the clonogenicity and proliferation of RDEB tumor cells. The combined wound healing, anti-microbial, and anti-neoplastic effects indicate that calcipotriol may represent a vital therapeutic option for RDEB patients which we could demonstrate in a single-patient observation study.
Subject(s)
Anti-Bacterial Agents/pharmacology , Antineoplastic Agents/pharmacology , Calcitriol/analogs & derivatives , Dermatologic Agents/pharmacology , Epidermolysis Bullosa/metabolism , Keratinocytes/drug effects , Wound Healing , Aged , Antimicrobial Cationic Peptides/genetics , Antimicrobial Cationic Peptides/metabolism , Calcitriol/pharmacology , Cell Line , Cells, Cultured , Epidermolysis Bullosa/pathology , Humans , Keratinocytes/metabolism , Male , CathelicidinsABSTRACT
The daily renewal of the corpus epithelium is fuelled by adult stem cells residing within tubular glands, but the identity of these stem cells remains controversial. Lgr5 marks homeostatic stem cells and 'reserve' stem cells in multiple tissues. Here, we report Lgr5 expression in a subpopulation of chief cells in mouse and human corpus glands. Using a non-variegated Lgr5-2A-CreERT2 mouse model, we show by lineage tracing that Lgr5-expressing chief cells do not behave as corpus stem cells during homeostasis, but are recruited to function as stem cells to effect epithelial renewal following injury by activating Wnt signalling. Ablation of Lgr5+ cells severely impairs epithelial homeostasis in the corpus, indicating an essential role for these Lgr5+ cells in maintaining the homeostatic stem cell pool. We additionally define Lgr5+ chief cells as a major cell-of-origin of gastric cancer. These findings reveal clinically relevant insights into homeostasis, repair and cancer in the corpus.
Subject(s)
Cell Proliferation , Cell Transformation, Neoplastic/metabolism , Chief Cells, Gastric/metabolism , Neoplastic Stem Cells/metabolism , Parietal Cells, Gastric/metabolism , Receptors, G-Protein-Coupled/genetics , Receptors, G-Protein-Coupled/metabolism , Regeneration , Stomach Neoplasms/metabolism , Animals , Biomarkers/metabolism , Cell Lineage , Cell Proliferation/drug effects , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/pathology , Chief Cells, Gastric/drug effects , Chief Cells, Gastric/pathology , Gene Expression Regulation , Genotype , Humans , Mice, Transgenic , Neoplastic Stem Cells/pathology , Organoids , Parietal Cells, Gastric/drug effects , Parietal Cells, Gastric/pathology , Phenotype , Regeneration/drug effects , Stomach Neoplasms/genetics , Stomach Neoplasms/pathology , Tamoxifen/toxicity , Tissue Culture Techniques , Wnt Signaling PathwayABSTRACT
Pluripotent stem cells have been proposed as an unlimited source of pancreatic ß cells for studying and treating diabetes. However, the long, multi-step differentiation protocols used to generate functional ß cells inevitably exhibit considerable variability, particularly when applied to pluripotent cells from diverse genetic backgrounds. We have developed culture conditions that support long-term self-renewal of human multipotent pancreatic progenitors, which are developmentally more proximal to the specialized cells of the adult pancreas. These cultured pancreatic progenitor (cPP) cells express key pancreatic transcription factors, including PDX1 and SOX9, and exhibit transcriptomes closely related to their in vivo counterparts. Upon exposure to differentiation cues, cPP cells give rise to pancreatic endocrine, acinar, and ductal lineages, indicating multilineage potency. Furthermore, cPP cells generate insulin+ ß-like cells in vitro and in vivo, suggesting that they offer a convenient alternative to pluripotent cells as a source of adult cell types for modeling pancreatic development and diabetes.
Subject(s)
Cell Self Renewal/physiology , Pluripotent Stem Cells/cytology , Stem Cells/cytology , Animals , Cell Differentiation/drug effects , Cell Line , Down-Regulation , Feeder Cells/cytology , Feeder Cells/metabolism , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Humans , Insulin/pharmacology , Insulin-Secreting Cells/cytology , Insulin-Secreting Cells/metabolism , Kidney/metabolism , Kidney/pathology , Mice , Mice, Inbred NOD , Mice, SCID , Pancreas/cytology , Pluripotent Stem Cells/metabolism , SOX9 Transcription Factor/metabolism , Stem Cells/metabolism , Trans-Activators/metabolism , Transplantation, HeterologousSubject(s)
Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Hypoxia/metabolism , Keratinocytes/physiology , Oxygen/metabolism , Skin Physiological Phenomena , Cell Proliferation , Cells, Cultured , Cluster Analysis , Filaggrin Proteins , Gene Expression Regulation , Humans , Hypoxia/pathology , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Interleukin-1/genetics , Intermediate Filament Proteins/genetics , Keratin-10/genetics , Primary Cell Culture , Protein Precursors/geneticsABSTRACT
BACKGROUND: Systemic telomere length has been associated with measures of diastolic function, vascular stiffness and left ventricular mass mainly in smaller, patient-specific settings and not in a general population. In this study we describe the applicability of these findings in a large, representative population. METHODS AND RESULTS: Peripheral blood leukocyte telomere length (PBL TL) was measured using telomere restriction fragment analysis in the young to middle-aged (>2500 volunteers, â¼35 to 55 years old) Asklepios study population, free from overt cardiovascular disease. Subjects underwent extensive echocardiographic, hemodynamic and biochemical phenotyping. After adjusting for relevant confounders (age, sex, systolic blood pressure, heart rate, body mass index and use of antihypertensive drugs) we found no associations between PBL TL and left ventricular mass index (Pâ=â0.943), ejection fraction (Pâ=â0.933), peak systolic septal annular motion (Pâ=â0.238), pulse wave velocity (Pâ=â0.971) or pulse pressure (Pâ=â0.999). In contrast, our data showed positive associations between PBL TL and parameters of LV filling: the transmitral flow early (E) to late (A) velocity ratio (E/A-ratio; P<0.001), the ratio of early (e') to late (a') mitral annular velocities (e'/a'-ratio; Pâ=â0.012) and isovolumic relaxation time (Pâ=â0.015). Interestingly, these associations were stronger in women than in men and were driven by associations between PBL TL and the late diastolic components (A and a'). CONCLUSIONS: In a generally healthy, young to middle-aged population, PBL TL is not related to LV mass or systolic function, but might be associated with an altered LV filling pattern, especially in women.
Subject(s)
Heart/physiology , Leukocytes/physiology , Myocardial Contraction/physiology , Telomere/metabolism , Vascular Stiffness/physiology , Adult , Blood Pressure/physiology , Cross-Sectional Studies , Female , Heart Rate/physiology , Humans , Male , Middle AgedSubject(s)
Epidermolysis Bullosa Dystrophica/microbiology , Microbiota/physiology , Skin/microbiology , Staphylococcaceae/physiology , Wounds and Injuries/microbiology , Adult , Aged , Austria/epidemiology , Biodiversity , Chile/epidemiology , Cohort Studies , Epidermolysis Bullosa Dystrophica/epidemiology , Epidermolysis Bullosa Dystrophica/genetics , Female , Genes, Recessive , Humans , Male , Metagenome , Middle Aged , Skin/pathology , Wounds and Injuries/pathology , Young AdultABSTRACT
BACKGROUND: Moderate to small heritability has been observed for left ventricular (LV) structure and function in genetic epidemiology and genomewide association studies. The aim of this study was to explore whether this would be mirrored in an independent association between LV structure and function and a family history (FH) of cardiovascular disease (CVD) in a large population of middle-aged adults. METHODS: Subjects enrolled in the Asklepios Study, a population-based sample of 2,524 male and female volunteers, aged 35 to 55 years, free of overt CVD at baseline, were studied. LV structure and function were assessed using transthoracic echocardiography (by a single sonographer). FH data spanning 4 generations were acquired using a questionnaire. RESULTS: In unadjusted analyses, only small effects of FH of CVD on LV structure (relative wall thickness, P = .042; interventricular septal thickness, P = .002; LV mass, P = .038; allometrically adjusted LV mass, P = .014) and diastolic function (mitral annular e', P = .02) were observed. After adjusting for the more adverse risk factor profile associated with FH, no significant associations persisted. These results did not appreciably change using a more extended definition of FH of CVD or FH of hypertension. CONCLUSIONS: A positive FH for CVD was associated with differences in offspring cardiac structure and function, largely mediated by (but not independent from) a more adverse risk profile in those subjects with positive FH.
Subject(s)
Echocardiography/statistics & numerical data , Genetic Predisposition to Disease/epidemiology , Genetic Predisposition to Disease/genetics , Stroke Volume , Ventricular Dysfunction, Left/epidemiology , Ventricular Dysfunction, Left/genetics , Adult , Belgium/epidemiology , Female , Humans , Male , Middle Aged , Prevalence , Reproducibility of Results , Risk Factors , Sensitivity and SpecificityABSTRACT
OBJECTIVES: Whereas the importance of family history (FH) is widely recognized in cardiovascular risk assessment, its full potential could be underutilized, when applied with its current simple guidelines-based definition (cFH): presence of premature cardiovascular disease (CVD) in a first-degree relative. We tested the added value of a new, extended family history definition (eFH), also taking into account later onset of disease, second-degree relatives and number of affected relatives, on profiling cardiovascular risk and atherosclerotic burden in the general population. DESIGN: Longitudinal population study. SETTING: Random, representative population sample from Erpe-Mere and Nieuwerkerken (Belgium, primary care). SUBJECTS: 2524 male/female volunteers, aged 35-55 years, free from overt CVD. MAIN OUTCOME MEASURES: Subjects were extensively phenotyped including presence of atherosclerosis (ultrasound) and a newly developed FH questionnaire (4 generations). RESULTS: Compared to cFH, eFH was superior in predicting an adverse risk profile (glycemic state, elevated blood pressure, lipid abnormalities, presence of metabolic syndrome components) and presence of atherosclerosis (all age & sex-adjusted p<0.05). Unlike cFH, eFH remained a significant predictor of subclinical atherosclerosis after adjusting for confounders. Most relations with eFH were not graded but showed clear informational breakpoints, with absence of CVD (including late onset) in any first-degree relative being a negative predictor of atherosclerosis, and a particularly interesting phenotype for further study. CONCLUSIONS: A novel, extended FH definition is superior to the conventional definition in profiling cardiovascular risk and atherosclerotic burden in the general population. There remain clear opportunities to refine and increase the performance and informational content of this simple, readily-available inexpensive tool.